Health Catalyst Appoints Ben Albert to the Role of President and COO
HCAT(NASDAQ:HCAT) Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement SALT LAKE CITY, Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to...
Health Catalyst Announces Winners of the 2025 Catalyst Awards
HCAT(NASDAQ:HCAT) Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
HCATHospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and...
Health Catalyst to Participate in Upcoming Investor Conferences
HCATSALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities
HCATMr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
Health Catalyst Reports Second Quarter 2025 Results
HCATSALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025.
Breaking Down Health Catalyst: 9 Analysts Share Their Views
HCATStifel Maintains Hold on Health Catalyst, Raises Price Target to $5.5
HCATHealth Catalyst Affirms FY2025 Sales Guidance of $335.00M vs $334.18M Est
HCATHealth Catalyst Sees Q2 Sales $80.500M vs $82.83M Est
HCATHealth Catalyst Q1 Adj. EPS $0.01 Down From $0.05 YoY, Sales $79.41M Beat $79.17M Estimate
HCATHealth Catalyst Partners With Microsoft To Accelerate AI Adoption And Transformation For Care Delivery Organizations
HCATCitigroup Maintains Buy on Health Catalyst, Lowers Price Target to $6.5
HCATKeybanc Maintains Overweight on Health Catalyst, Lowers Price Target to $5
HCATThis PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
HCATForecasting The Future: 10 Analyst Projections For Health Catalyst
HCATEvercore ISI Group Downgrades Health Catalyst to In-Line, Lowers Price Target to $4
HCATHealth Catalyst Announces ~$5M Stock Repurchase
HCAT10 Analysts Have This To Say About Health Catalyst
HCATStephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $5
HCATHealth Catalyst Announces A Multi-Year Agreement With Signature Healthcare, An Integrated Healthcare Delivery System Serving Southeastern Massachusetts
HCATRBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $6
HCATStifel Maintains Hold on Health Catalyst, Lowers Price Target to $5
HCATStephens & Co. Reiterates Equal-Weight on Health Catalyst, Maintains $7 Price Target
HCATHealth Catalyst Sees Q1 Sales $79.000M vs $81.99M Est
HCATHealth Catalyst Sees FY2025 Sales $335.000M vs $336.91M Est
HCATHealth Catalyst Q4 Adj $0.04 Misses $0.07 Estimate, Sales $79.61M Miss $79.67M Estimate
HCATRBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $7
HCATHealth Catalyst Announces Acquisition Of Upfront Healthcare Services, Expanding Patient Engagement Capabilities; Terms Not Disclosed
HCATCitigroup Maintains Buy on Health Catalyst, Lowers Price Target to $10
HCATStephens & Co. Maintains Equal-Weight on Health Catalyst, Raises Price Target to $9
HCATHealth Catalyst Signs Definitive Agreement To Acquire Top-Rated Cybersecurity Provider, Intraprise Health; No Financial Terms Disclosed
HCATCyncHealth Announces New Partnership With Health Catalyst To Elevate Health Data Management
HCATHealth Catalyst Narrows FY2024 Sales Guidance from $304.00M-312.00M to $305.00M-311.00M
HCATHealth Catalyst Sees Q4 Sales $78.000M-84.000M vs $80.69M Est
HCATHealth Catalyst Q3 2024 Adj. EPS $0.07 Misses $0.10 Estimate, Sales $76.353M Beat $76.301M Estimate
HCATPeeling Back The Layers: Exploring Health Catalyst Through Analyst Insights
HCATCanaccord Genuity Maintains Buy on Health Catalyst, Maintains $11 Price Target
HCATWhere Health Catalyst Stands With Analysts
HCATAnalysts have provided the following ratings for Health Catalyst (NASDAQ:HCAT) within the last quarter:
Piper Sandler Downgrades Health Catalyst to Neutral, Lowers Price Target to $11
HCAT